Dow Down1.50% Nasdaq Down2.41%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
0.57 Down 0.02(3.55%) 4:05PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Total Revenue 4,723   4,294   3,979   2,868  
Cost of Revenue535  515  458  333  
Gross Profit 4,188   3,778   3,522   2,535  
Operating Expenses
Research Development2,660  2,607  3,902  2,297  
Selling General and Administrative4,097  3,772  3,943  4,049  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,569) (2,601) (4,323) (3,811)
Income from Continuing Operations
Total Other Income/Expenses Net1,088  1,089  (1,573)(4,298)
Earnings Before Interest And Taxes(1,493)(4,258)(5,896)(5,406)
Interest Expense2,194  2,183  2,148  1,576  
Income Before Tax(3,686)(6,441)(8,044)(6,982)
Income Tax Expense -   -   -   -  
Minority Interest0  0  0  0  
Net Income From Continuing Ops(3,698)(3,270)(8,071)(9,428)
Non-recurring Events
Discontinued Operations -  759   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,698) (2,511) (8,071) (9,428)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,686) (2,510) (8,071) (9,691)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.